APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Asthma Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchAsthma Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Medication Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Asthma Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Medication Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Asthma Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Asthma Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Asthma Medication include Merck & Co. Inc, Roche Holdings Ltd, Glaxosmithkline plc, AstraZeneca plc, Theravance Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis and QVAR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Medication Segment by Company

Merck & Co. Inc

Roche Holdings Ltd

Glaxosmithkline plc

AstraZeneca plc

Theravance Inc

Sepracor, Inc

Schering-Plough Corp

Sanofi-Aventis

QVAR

MAP Pharmaceuticals，Inc

Genentech Inc

Dulera

Asthma Medication Segment by Type

Asthma Medications During Pregnancy

Quick-Relief Medications

Long-Term Control Medications

Asthma Medication Segment by Application

Children

Adolescent

Adult

Asthma Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Asthma Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Asthma Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Asthma Medication Industry Trends Table 2. Asthma Medication Industry Drivers Table 3. Asthma Medication Industry Opportunities and Challenges Table 4. Asthma Medication Industry Restraints Table 5. Global Asthma Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Asthma Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Asthma Medication Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Asthma Medication Sales Market Share by Manufacturers Table 9. Global Asthma Medication Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Asthma Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Asthma Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Asthma Medication Manufacturers, Product Type & Application Table 13. Global Asthma Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Asthma Medications During Pregnancy Table 17. Major Manufacturers of Quick-Relief Medications Table 18. Major Manufacturers of Long-Term Control Medications Table 19. Global Asthma Medication Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Asthma Medication Sales by Type (2021-2026) & (K Units) Table 21. Global Asthma Medication Sales by Type (2027-2032) & (K Units) Table 22. Global Asthma Medication Sales Market Share by Type (2021-2026) Table 23. Global Asthma Medication Sales Market Share by Type (2027-2032) Table 24. Global Asthma Medication Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Asthma Medication Revenue by Type (2021-2026) & (K Units) Table 26. Global Asthma Medication Revenue by Type (2027-2032) & (K Units) Table 27. Global Asthma Medication Revenue Market Share by Type (2021-2026) Table 28. Global Asthma Medication Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Children Table 30. Major Manufacturers of Adolescent Table 31. Major Manufacturers of Adult Table 32. Global Asthma Medication Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Asthma Medication Sales by Application (2021-2026) & (K Units) Table 34. Global Asthma Medication Sales by Application (2027-2032) & (K Units) Table 35. Global Asthma Medication Sales Market Share by Application (2021-2026) Table 36. Global Asthma Medication Sales Market Share by Application (2027-2032) Table 37. Global Asthma Medication Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Asthma Medication Revenue by Application (2021-2026) & (K Units) Table 39. Global Asthma Medication Revenue by Application (2027-2032) & (K Units) Table 40. Global Asthma Medication Revenue Market Share by Application (2021-2026) Table 41. Global Asthma Medication Revenue Market Share by Application (2027-2032) Table 42. Global Asthma Medication Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Asthma Medication Sales by Region (2021-2026) & (K Units) Table 44. Global Asthma Medication Sales Market Share by Region (2021-2026) Table 45. Global Asthma Medication Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Asthma Medication Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Asthma Medication Sales by Country (2021-2026) & (K Units) Table 49. North America Asthma Medication Sales by Country (2027-2032) & (K Units) Table 50. Europe Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Asthma Medication Sales by Country (2021-2026) & (K Units) Table 52. Europe Asthma Medication Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Asthma Medication Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Asthma Medication Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Asthma Medication Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Asthma Medication Sales by Country (2027-2032) & (K Units) Table 59. Global Asthma Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Asthma Medication Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Asthma Medication Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Asthma Medication Revenue Market Share by Region (2021-2026) Table 63. Global Asthma Medication Revenue Market Share by Region (2027-2032) Table 64. Merck & Co. Inc Company Information Table 65. Merck & Co. Inc Business Overview Table 66. Merck & Co. Inc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck & Co. Inc Asthma Medication Product Portfolio Table 68. Merck & Co. Inc Recent Development Table 69. Roche Holdings Ltd Company Information Table 70. Roche Holdings Ltd Business Overview Table 71. Roche Holdings Ltd Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Holdings Ltd Asthma Medication Product Portfolio Table 73. Roche Holdings Ltd Recent Development Table 74. Glaxosmithkline plc Company Information Table 75. Glaxosmithkline plc Business Overview Table 76. Glaxosmithkline plc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Glaxosmithkline plc Asthma Medication Product Portfolio Table 78. Glaxosmithkline plc Recent Development Table 79. AstraZeneca plc Company Information Table 80. AstraZeneca plc Business Overview Table 81. AstraZeneca plc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca plc Asthma Medication Product Portfolio Table 83. AstraZeneca plc Recent Development Table 84. Theravance Inc Company Information Table 85. Theravance Inc Business Overview Table 86. Theravance Inc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Theravance Inc Asthma Medication Product Portfolio Table 88. Theravance Inc Recent Development Table 89. Sepracor, Inc Company Information Table 90. Sepracor, Inc Business Overview Table 91. Sepracor, Inc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sepracor, Inc Asthma Medication Product Portfolio Table 93. Sepracor, Inc Recent Development Table 94. Schering-Plough Corp Company Information Table 95. Schering-Plough Corp Business Overview Table 96. Schering-Plough Corp Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Schering-Plough Corp Asthma Medication Product Portfolio Table 98. Schering-Plough Corp Recent Development Table 99. Sanofi-Aventis Company Information Table 100. Sanofi-Aventis Business Overview Table 101. Sanofi-Aventis Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Sanofi-Aventis Asthma Medication Product Portfolio Table 103. Sanofi-Aventis Recent Development Table 104. QVAR Company Information Table 105. QVAR Business Overview Table 106. QVAR Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. QVAR Asthma Medication Product Portfolio Table 108. QVAR Recent Development Table 109. MAP Pharmaceuticals，Inc Company Information Table 110. MAP Pharmaceuticals，Inc Business Overview Table 111. MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio Table 113. MAP Pharmaceuticals，Inc Recent Development Table 114. Genentech Inc Company Information Table 115. Genentech Inc Business Overview Table 116. Genentech Inc Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Genentech Inc Asthma Medication Product Portfolio Table 118. Genentech Inc Recent Development Table 119. Dulera Company Information Table 120. Dulera Business Overview Table 121. Dulera Asthma Medication Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Dulera Asthma Medication Product Portfolio Table 123. Dulera Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Asthma Medication Distributors List Table 127. Asthma Medication Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Asthma Medication Product Image Figure 2. Global Asthma Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Asthma Medication Sales (2021-2032) & (K Units) Figure 5. Global Asthma Medication Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Asthma Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Asthma Medications During Pregnancy Image Figure 9. Quick-Relief Medications Image Figure 10. Long-Term Control Medications Image Figure 11. Global Asthma Medication Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Asthma Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Asthma Medication Sales Market Share by Type (2021-2032) Figure 14. Global Asthma Medication Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Asthma Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Asthma Medication Revenue Market Share by Type (2021-2032) Figure 17. Children Image Figure 18. Adolescent Image Figure 19. Adult Image Figure 20. Global Asthma Medication Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Asthma Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Asthma Medication Sales Market Share by Application (2021-2032) Figure 23. Global Asthma Medication Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Asthma Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Asthma Medication Revenue Market Share by Application (2021-2032) Figure 26. North America Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Asthma Medication Sales Market Share by Country (2021-2032) Figure 28. U.S. Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Asthma Medication Sales Market Share by Country (2021-2032) Figure 33. Germany Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Asthma Medication Sales Market Share by Country (2021-2032) Figure 40. China Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Asthma Medication Sales Market Share by Country (2021-2032) Figure 48. Brazil Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Asthma Medication Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Asthma Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Asthma Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Asthma Medication Revenue (2021-2032) & (US$ Million) Figure 59. North America Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Asthma Medication Revenue (2021-2032) & (US$ Million) Figure 61. Europe Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Asthma Medication Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Asthma Medication Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asthma Medication Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Asthma Medication Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Asthma Medications During Pregnancy
  • Quick-Relief Medications
  • Long-Term Control Medications
Applications
  • Children
  • Adolescent
  • Adult
Companies covered
  • Merck & Co. Inc
  • Roche Holdings Ltd
  • Glaxosmithkline plc
  • AstraZeneca plc
  • Theravance Inc
  • Sepracor, Inc
  • Schering-Plough Corp
  • Sanofi-Aventis
  • QVAR
  • MAP Pharmaceuticals，Inc
  • Genentech Inc
  • Dulera

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Asthma Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Asthma Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Asthma Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Asthma Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Asthma Medication Market Dynamics
  1. 2.1 Asthma Medication Industry Trends
  2. 2.2 Asthma Medication Industry Drivers
  3. 2.3 Asthma Medication Industry Opportunities and Challenges
  4. 2.4 Asthma Medication Industry Restraints
3 Asthma Medication Market by Manufacturers
  1. 3.1 Global Asthma Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Asthma Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Asthma Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Asthma Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Asthma Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Asthma Medication Manufacturers, Product Type & Application
  7. 3.7 Global Asthma Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Asthma Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Asthma Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Asthma Medication Tier 1, Tier 2, and Tier 3
4 Asthma Medication Market by Type
  1. 4.1 Asthma Medication Type Introduction
  2. 4.1.1 Asthma Medications During Pregnancy
  3. 4.1.2 Quick-Relief Medications
  4. 4.1.3 Long-Term Control Medications
  5. 4.2 Global Asthma Medication Sales by Type
  6. 4.2.1 Global Asthma Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Asthma Medication Sales by Type (2021-2032)
  8. 4.2.3 Global Asthma Medication Sales Market Share by Type (2021-2032)
  9. 4.3 Global Asthma Medication Revenue by Type
  10. 4.3.1 Global Asthma Medication Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Asthma Medication Revenue by Type (2021-2032)
  12. 4.3.3 Global Asthma Medication Revenue Market Share by Type (2021-2032)
5 Asthma Medication Market by Application
  1. 5.1 Asthma Medication Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adolescent
  4. 5.1.3 Adult
  5. 5.2 Global Asthma Medication Sales by Application
  6. 5.2.1 Global Asthma Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Medication Sales by Application (2021-2032)
  8. 5.2.3 Global Asthma Medication Sales Market Share by Application (2021-2032)
  9. 5.3 Global Asthma Medication Revenue by Application
  10. 5.3.1 Global Asthma Medication Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Asthma Medication Revenue by Application (2021-2032)
  12. 5.3.3 Global Asthma Medication Revenue Market Share by Application (2021-2032)
6 Global Asthma Medication Sales by Region
  1. 6.1 Global Asthma Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Asthma Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Asthma Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Asthma Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Asthma Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Asthma Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Asthma Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Asthma Medication Revenue by Region
  1. 7.1 Global Asthma Medication Revenue by Region
  2. 7.1.1 Global Asthma Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Asthma Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Asthma Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Asthma Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Asthma Medication Revenue (2021-2032)
  8. 7.2.2 North America Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Asthma Medication Revenue (2021-2032)
  11. 7.3.2 Europe Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Asthma Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Asthma Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Asthma Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co. Inc
  2. 8.1.1 Merck & Co. Inc Company Information
  3. 8.1.2 Merck & Co. Inc Business Overview
  4. 8.1.3 Merck & Co. Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co. Inc Asthma Medication Product Portfolio
  6. 8.1.5 Merck & Co. Inc Recent Developments
  7. 8.2 Roche Holdings Ltd
  8. 8.2.1 Roche Holdings Ltd Company Information
  9. 8.2.2 Roche Holdings Ltd Business Overview
  10. 8.2.3 Roche Holdings Ltd Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Holdings Ltd Asthma Medication Product Portfolio
  12. 8.2.5 Roche Holdings Ltd Recent Developments
  13. 8.3 Glaxosmithkline plc
  14. 8.3.1 Glaxosmithkline plc Company Information
  15. 8.3.2 Glaxosmithkline plc Business Overview
  16. 8.3.3 Glaxosmithkline plc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
  18. 8.3.5 Glaxosmithkline plc Recent Developments
  19. 8.4 AstraZeneca plc
  20. 8.4.1 AstraZeneca plc Company Information
  21. 8.4.2 AstraZeneca plc Business Overview
  22. 8.4.3 AstraZeneca plc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca plc Asthma Medication Product Portfolio
  24. 8.4.5 AstraZeneca plc Recent Developments
  25. 8.5 Theravance Inc
  26. 8.5.1 Theravance Inc Company Information
  27. 8.5.2 Theravance Inc Business Overview
  28. 8.5.3 Theravance Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Theravance Inc Asthma Medication Product Portfolio
  30. 8.5.5 Theravance Inc Recent Developments
  31. 8.6 Sepracor, Inc
  32. 8.6.1 Sepracor, Inc Company Information
  33. 8.6.2 Sepracor, Inc Business Overview
  34. 8.6.3 Sepracor, Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sepracor, Inc Asthma Medication Product Portfolio
  36. 8.6.5 Sepracor, Inc Recent Developments
  37. 8.7 Schering-Plough Corp
  38. 8.7.1 Schering-Plough Corp Company Information
  39. 8.7.2 Schering-Plough Corp Business Overview
  40. 8.7.3 Schering-Plough Corp Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Schering-Plough Corp Asthma Medication Product Portfolio
  42. 8.7.5 Schering-Plough Corp Recent Developments
  43. 8.8 Sanofi-Aventis
  44. 8.8.1 Sanofi-Aventis Company Information
  45. 8.8.2 Sanofi-Aventis Business Overview
  46. 8.8.3 Sanofi-Aventis Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi-Aventis Asthma Medication Product Portfolio
  48. 8.8.5 Sanofi-Aventis Recent Developments
  49. 8.9 QVAR
  50. 8.9.1 QVAR Company Information
  51. 8.9.2 QVAR Business Overview
  52. 8.9.3 QVAR Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 QVAR Asthma Medication Product Portfolio
  54. 8.9.5 QVAR Recent Developments
  55. 8.10 MAP Pharmaceuticals，Inc
  56. 8.10.1 MAP Pharmaceuticals，Inc Company Information
  57. 8.10.2 MAP Pharmaceuticals，Inc Business Overview
  58. 8.10.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MAP Pharmaceuticals，Inc Asthma Medication Product Portfolio
  60. 8.10.5 MAP Pharmaceuticals，Inc Recent Developments
  61. 8.11 Genentech Inc
  62. 8.11.1 Genentech Inc Company Information
  63. 8.11.2 Genentech Inc Business Overview
  64. 8.11.3 Genentech Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Genentech Inc Asthma Medication Product Portfolio
  66. 8.11.5 Genentech Inc Recent Developments
  67. 8.12 Dulera
  68. 8.12.1 Dulera Company Information
  69. 8.12.2 Dulera Business Overview
  70. 8.12.3 Dulera Asthma Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dulera Asthma Medication Product Portfolio
  72. 8.12.5 Dulera Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Medication Value Chain Analysis
  2. 9.1.1 Asthma Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Medication Production Mode & Process
  6. 9.2 Asthma Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Medication Distributors
  9. 9.2.3 Asthma Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst